Atlas Trials

Postmarketing Surveillance Study of Berotec® N 100 µg Metered-dose Inhaler in Chronic Obstructive Respiratory Tract Disease

Clinical trial NCT02244216 · COMPLETED

Trial details

NCT number
NCT02244216
Sponsor
Boehringer Ingelheim
Status
COMPLETED
Study type
OBSERVATIONAL
Pulmonary Disease, Chronic Obstructive
Start date
2000-04-01
Primary completion
2000-06-01
Enrollment
2914

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.